These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 29866876)
21. In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012. Walkty A; Adam H; Baxter M; Denisuik A; Lagacé-Wiens P; Karlowsky JA; Hoban DJ; Zhanel GG Antimicrob Agents Chemother; 2014 May; 58(5):2554-63. PubMed ID: 24550325 [TBL] [Abstract][Full Text] [Related]
25. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. Ontong JC; Ozioma NF; Voravuthikunchai SP; Chusri S PLoS One; 2021; 16(1):e0244673. PubMed ID: 33406110 [TBL] [Abstract][Full Text] [Related]
26. Screening and Characterization of Multidrug-Resistant Gram-Negative Bacteria from a Remote African Area, São Tomé and Príncipe. Poirel L; Aires-de-Sousa M; Kudyba P; Kieffer N; Nordmann P Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941640 [TBL] [Abstract][Full Text] [Related]
27. In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions. Castanheira M; Davis AP; Serio AW; Krause KM; Mendes RE Diagn Microbiol Infect Dis; 2019 May; 94(1):73-77. PubMed ID: 30661726 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755 [TBL] [Abstract][Full Text] [Related]
29. Synergistic Combinations and Repurposed Antibiotics Active against the Pandrug-Resistant Klebsiella pneumoniae Nevada Strain. Brennan-Krohn T; Kirby JE Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307981 [No Abstract] [Full Text] [Related]
30. ARGONAUT II Study of the Jacobs MR; Good CE; Hujer AM; Abdelhamed AM; Rhoads DD; Hujer KM; Rudin SD; Domitrovic TN; Connolly LE; Krause KM; Patel R; Arias CA; Kreiswirth BN; Rojas LJ; D'Souza R; White RC; Brinkac LM; Nguyen K; Singh I; Fouts DE; van Duin D; Bonomo RA; Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152078 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the Rapid Polymyxin NP test for detection of colistin susceptibility in Enterobacteriaceae isolated from Thai patients. Yainoy S; Hiranphan M; Phuadraksa T; Eiamphungporn W; Tiengrim S; Thamlikitkul V Diagn Microbiol Infect Dis; 2018 Oct; 92(2):102-106. PubMed ID: 29884562 [TBL] [Abstract][Full Text] [Related]
32. High Prevalence of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Wild Fish from the Mediterranean Sea in Algeria. Brahmi S; Touati A; Dunyach-Remy C; Sotto A; Pantel A; Lavigne JP Microb Drug Resist; 2018 Apr; 24(3):290-298. PubMed ID: 28805537 [TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of plazomicin MICs obtained using agar dilution versus broth microdilution methods and impact of inoculum size against ESBL-producing Escherichia coli, carbapenemase-producing Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus clinical isolates. Emiliov T; Rodríguez-Avial I; López-Diaz MDC; Culebras E Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114867. PubMed ID: 31402069 [TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV; J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of plazomicin against quinolone-resistant gram-negative bacteria isolated from catheter-associated urinary tract infections. Abd-Elmonsef MME; Nagla S; Afandy ME; Maxwell SY J Chemother; 2021 Nov; 33(7):462-468. PubMed ID: 33810779 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study. Seifert H; Blondeau J; Dowzicky MJ Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439 [TBL] [Abstract][Full Text] [Related]
38. Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method. Mezzatesta ML; Caio C; Gona F; Zingali T; Salerno I; Stefani S Microb Drug Resist; 2016 Jul; 22(5):360-3. PubMed ID: 26909754 [TBL] [Abstract][Full Text] [Related]